Skip to content

Strep A FIA Field Study, Sofia

Sofia Strep A FIA Field Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02153008
Enrollment
1708
Registered
2014-06-02
Start date
2014-04-30
Completion date
2016-07-01
Last updated
2017-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Group A Streptococcus

Keywords

Strep throat

Brief summary

To demonstrate the clinical performance of the Strep A FIA and Sofia, using throat swabs collected from symptomatic subjects.

Interventions

None listed

Sponsors

Quidel Corporation
Lead SponsorINDUSTRY

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
3 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Male and Female, 3 years of age or older 2. Must currently be exhibiting one or more of the symptoms characteristic of pharyngitis to be eligible for inclusion in this study. For example: 1. Acute onset of sore throat 2. Redness of the posterior pharyngeal wall 3. Difficulty/pain on swallowing 4. Fever, \> 37.8º C (100ºF) at presentation or within past 24 hours 5. Pharyngeal exudate 6. Tender cervical lymphadenopathy 7. Absence of cough, runny nose or other upper respiratory symptoms.\* 8. Other, symptoms specific to Strep A not listed above. * Must include at least one additional symptom from a-f and cannot be the only criteria used to meet inclusion for enrollment in the study.

Exclusion criteria

1. Subjects currently under treatment with antibiotics are not to be included in this study. 2. At clinical sites requiring informed consent, unable to understand and consent to participation; for minors this includes parent or legal guardian.

Design outcomes

Primary

MeasureTime frameDescription
Detection of Group A StreptococcusWithin 5 minutesA throat swab specimen will be obtained and tested for the presence of Group A Streptococcus via the Sofia Analyzer

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026